Bill Summary & Status for the 107th Congress

NEW SEARCH | HOME | HELP

H.AMDT.285 (A003) Substitute amendment
Amends: H.R.2505
Sponsor: Rep Greenwood, James C. [PA-8] (offered 7/31/2001)

AMENDMENT DESCRIPTION:
Amendment in the nature of a substitute sought to ban the use of human somatic cell nuclear transfer technology to initiate a pregnancy but allow the use of somatic cell nuclear transfer technology to clone molecules, DNA, cells, or tissues; require each individual who intends to perform human somatic cell nuclear transfer technology to register with the Secretary of Health and Human Services; sunset the ban ten years after enactment; require those who break the law to forfeit equipment, other property, and any monetary gains; and require a study by the Institute of Medicine on the properties of embryonic, fetal and adult stem cells.

AMENDMENT PURPOSE:
An amendment in the nature of a substitute numbered 2 printed in House Report 107-172 to make it a criminal act, subject to criminal and civil penalties, to use somatic cell nuclear transfer, or the products from this technology, to initiate a pregnancy or with the intent to initiate a pregnancy; to make it illegal to ship, mail, transport, or receive the products of somatic cell nuclear transfer if the products will be used to initiate a pregnancy; to protect other uses of somatic cell nuclear transfer, including therapeutic cloning; to require all individuals or companies who plan to perform somatic cell nuclear transfer to register with the Secretary and attest that they know that initiating a pregnancy through such means is illegal; to provide that such registration is deemed confidential, following the same fashion as the FDA's treatment of trade secrets when a company files an Investigational New Drug application; to preempt future state laws that are different from federal cloning law or prohibit protected types of research; to sunset the ban ten years after enactment; to require those who break the law to forfeit equipment, other property, and any monetary gains; and to require a study by the Institute of Medicine on the properties of embryonic, fetal and adult stem cells.

STATUS: